Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Genocea Biosciences (GNCA)

2.69   0.06 (2.28%) 03-07 04:03
Open: 2.65 Pre. Close: 2.63
High: 2.73 Low: 2.41
Volume: 361,197 Market Cap: 144M
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to profile patient's CD4+ and CD8+ T cell immune responses to potential target or antigen in that patient's tumor. It develops immuno-oncology programs, such as GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in the phase I/IIa clinical trial; GEN-011, a neoantigen adoptive T cell therapy program; and GEN-010, a neoantigen vaccine program. Genocea Biosciences, Inc. was founded in 2006 and is based in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.731 - 2.748 2.748 - 2.764
Low: 2.375 - 2.392 2.392 - 2.409
Close: 2.66 - 2.689 2.689 - 2.716

Technical analysis

as of: 2021-03-05 5:08:37 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.00     One year: 4.72
Support: Support1: 2.41    Support2: 2.01
Resistance: Resistance1: 3.42    Resistance2: 4.05
Pivot: 3.20
Moving Average: MA(5): 2.86     MA(20): 3.24
MA(100): 2.59     MA(250): 2.46
MACD: MACD(12,26): -0.06     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 12.45     %D(3): 14.04
RSI: RSI(14): 41.80
52-week: High: 5.75  Low: 1.10  Change(%): 34.5
Average Vol(K): 3-Month: 62848  10-Days: 43015

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
GNCA has closed above bottom band by 14.5%. Bollinger Bands are 107% wider than normal. The large width of the bands suggest high volatility as compared to GNCA's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Tue, 02 Mar 2021
Genocea to Present at the H.C. Wainwright Global Life Sciences Conference - Yahoo Finance

Tue, 23 Feb 2021
What is the Forecast Price for GNCA (GNCA) Stock Tuesday? - InvestorsObserver

Thu, 18 Feb 2021
Genocea Biosciences - Consensus Indicates Potential 91.2% Upside - DirectorsTalk Interviews

Thu, 18 Feb 2021
What Type Of Returns Would Genocea Biosciences'(NASDAQ:GNCA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago? - Simply Wall St

Thu, 18 Feb 2021
Genocea Biosciences Inc (GNCA) Stock: Buy, Hold, or Sell? - InvestorsObserver

Tue, 16 Feb 2021
Should Genocea Biosciences Inc (GNCA) Stock Be in Your Portfolio? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52
Shares Float (M) 27
% Held by Insiders 6.98
% Held by Institutions 54.72
Shares Short (K) 1,680
Shares Short P. Month (K) 1,630

Stock Financials

EPS -1.399
EPS Est This Year -1.920
EPS Est Next Year -1.110
Book Value (p.s.) 0.390
Profit Margin
Operating Margin -3321.34
Return on Assets (ttm) -34.1
Return on Equity (ttm) -147.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share 0.026
EBITDA (p.s.) -0.860
Qtrly Earnings Growth
Operating Cash Flow (M) -41
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -1.92
PEG Ratio
Price to Book value 6.90
Price to Sales 102.14
Price to Cash Flow -3.39

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.